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Summary 
Mice lacking cyclin Dl have been generated by gene 
targeting in embryonic stem cells. Dyclin Dl -deficient 
animals develop to term but show reduced body size, 
reduced viability, and symptoms of neurological im- 
pairment. Their retinas display a striking reduction in 
cell number due to proliferative failure during embry- 
onic development. in situ hybridization studies of nor- 
mal mouse embryos revealed an extremely high level 
of cyclin Dl in the retina, suggesting a special depen- 
dence of this tissue on cyciin Dl. In adult mutant fe- 
males, the breast epithelial compartment fails to un- 
dergo the massive proliferative changes associated 
with pregnancy despite normal levels of ovarian ste- 
roid hormones. Thus, steroid-induced proliferation of 
mammary epitheiium during pregnancy may be driven 
through cyclin Dl. 
Introduction 
The control of mammalian cell proliferation by extracellu- 
lar signals occurs largely during the Gl phase of the cell 
cycle. During this period, growth stimulatory and growth 
inhibitory signals transduced from the extracellular envi- 
ronment converge on the cell cycle clock operating in the 
cell nucleus. This apparatus, composed of cyclins and 
their associated cyclin-dependent kinases (CDKs), may 
respond by setting into motion an autonomous cell division 
program that carries the cells through S, G2, and M phases 
or, alternatively, by causing exit from the cell cycle into 
the quiescent GO state (reviewed by Sherr, 1994). 
Once formed and activated in Gl , complexes of specific 
cyclins and CDKs trigger cell cycle progression by phos- 
phorylating critical cellular substrate proteins. Four mam- 
malian Gl cyclins have been enumerated to date: cyclins 
Dl, D2, and D3 (D-type cyclins) and cyclin E. Expression 
of the D cyclins is rapidly induced upon exposure of cells 
to mitogens; this expression declines when mitogens are 
withdrawn or antiproliferative agents are added (reviewed 
by Sherr, 1994). 
Recent studies suggest that the major target of cyclin 
D-mediated phosphorylation is the retinoblastoma tumor 
suppressor gene product, pRB. Indeed, pRB may be the 
only important rate-limiting substrate of cyclin D-CDK 
complexes, in that the growth of cells lacking pRB no 
longer requires cyclin D (reviewed by Weinberg, 1995). 
In many types of human tumor cells, the expression of 
cyclin Dl is deregulated, favoring the phosphorylation and 
functional inactivation of pRB. Indeed, the cyciin Dl gene 
wasoriginally cloned as an oncogene, termed PRADl, that 
was found to be activated by chromosomal translocations 
present in the genomes of parathyroid adenoma cells (Mo- 
tokura et al., 1991). Consistent with the oncogenic role of 
cyclin Dl are observations that transgenic mice engi- 
neered to overexpress this cyclin in their breast tissue are 
prone to mammary adenocarcinomas (Wang et al., 1994) 
while coexpression of cyclin Dl and myc genes in the 
lymphoid tissue of transgenic mice leads to rapid develop- 
ment of lymphomas (Bodrug et al., 1994; Lovec et al., 
1994). 
Several lines of evidence suggest that particular D 
cyclins may have specialized functions in distinct cell 
types, despite the fact that they share substantial se- 
quence homology (Matsushime et al., 1991a; Xiong et al., 
1992) and a common affinity for interacting with CDK4 and 
CDK8 (reviewed by Sherr, 1994). Each of the D cyclins 
has its own distinct pattern of tissue-specific expression 
and accumulate8 with distinct kinetics following mitogen 
challenge, hinting at specialized roles in cell cycle progres- 
sion (Matsushime et al., 1991 b; Motokura et al., 1992). In 
addition, the various D cyclins display dramatically dif- 
ferent patterns of expression during the terminal differenti- 
ation of muscle cells (Rao et al., 1994; Kiess et al., 1995; 
Skapek et al., 1995) and neurons (Tamaru et al., 1993, 
1994). 
To understand the distinct roles played by the D cyclins 
in the proliferation and differentiation of various cell types, 
we have used the technique of gene targeting in embryonic 
stem (ES) cells and created mice lacking cyclin Dl , D2, 
or D3. In the present paper, we describe mice that lack 
cyclin Dl. We report here that mice deficient in cyclin Dl, 
a presumed vital component in promoting cell prolifera- 
tion, are viable and show deficiencies restricted to a sur- 
prisingly narrow set of tissues. 
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Figure 1. Targeted Disruption of the Mouse 
Cyclin Dl Gene 
(A) Restriction map of the mouse cyctin Dl 
gene, the targeting vector, and the structure of 
the mutated locus following the homologous 
recombination. The coding exons are depicted 
by stippled boxes and are numbered; the open 
box denotes the noncoding portion of the first 
exon. The structure of the noncoding portion 
of the fifth exon hashot been determined. Ge- 
nomic fragments used as probes for Southern 
blotting are depicted as closed boxes (probe 
A and probe 6); arrows denote PCR primers 
(C. H, and IV) used for genotyping the animals. 
Abbreviations and symbols: NEO, the neomy- 
cin transferase gene; TK, thymidine kinase 
gene; arrows show transcriptional orientation 
of these genes. Only relevant restriction sites 
are shown. The distal 4.1 kb of the presented 
genomic fragment (preceding the Sfil site) has 
not been fully restriction mapped and hence 
may contain additional sites. Restriction enzyme abbreviations: R. EcoRI; X, Xbal; E, Eagl; H, Hindlll; A, Asp716; Xh, Xhol; S, Salk Sf, Sfil. 
(B) Southern blot analysis of genomic DNA extracted from ES cell clones. The DNA was digested with Xbal and hybridized with probe A. The 
sizes of wild-type (W.T.) and disrupted (K.O.) alleles are shown; the genotypes of ES cell clones are presented above the lanes. 
(C) PCR amplification products of the DNA extracted from mouse tails. The sizes of amplification products of wild-type (W.T.) and disrupted (K.O.) 
alleles are shown; the genotypes of animals are presented above the lanes. 
(D) Western blot analysis of extracts prepared from wild-type and cyclin DV- mouse embryonic fibroblasts. The blot was probed with rabbit 
polyclonal anti-cyclin Dl serum. Bands corresponding to cyclin Dl are indicated. The genotypes of mouse embryos from which fibroblasts were 
derived are shown above the lanes. 
Results 
Generation of Cyclin Dl-I- Mice 
To create a targeted mutation in the murine cyclin Dl 
gene, we isolated the mouse genomic fragment encoding 
cyclin Dl and determined its physical map, including exonl 
intron structure (Figure 1 A). As is the case with its human 
counterpart (Motokura and Arnold, 1993), the coding se- 
quence of the mouse cyclin Dl gene is assembled from 
five exons that are spread over a genomic distance of 
more than 7 kb (Figure 1A). The exonlintron boundaries 
of murine cyclin Dl gene were found to lie at precisely 
the same sites as those reported for the human cyclin Dl 
(Motokura and Arnold, 1993) D2, and D3 genes (Inaba 
et al., 1992). 
We prepared a gene targeting construct by deleting a 
restriction fragment containing the coding portion of exon 
I as well as exons II and Ill and replacing it with a cassette 
expressing the neo gene. These exons were chosen for 
deletion because they encode the so-called cyclin box, a 
stretch of over 100 amino acid residues that is conserved 
among the cyclins of all eukaryotes and is believed to be 
essential for cyclin function (Xiong and Beach, 1991). 
Following electroporation, 141 ES clones were selected 
using the positive-negative selection method (Mansour 
et al., 1988) expanded, and screened for homologous 
recombination events by Southern blotting analysis of 
their DNA (Figure 1B). Of these, 52 clones (37%) were 
found to be heterozygous at the cyclin Dl locus. Six ES 
cell clones were expanded and injected into mouse blasto- 
cysts, yielding founder chimeric mice; two ES cell clones 
contributed to the germline in chimeric mice, giving rise 
to cyclin Dl heterozygotes. Heterozygotes were bred to 
produce cyclin Dl-‘- mice, which were identified by South- 
ern blotting and polymerase chain reaction (PCR) amplifi- 
cation of tail DNA (Figure 1C). The absence of cyclin Dl 
protein in mutant mice was confirmed by Western immu- 
noblot analysisof embryonal fibroblast lysates (Figure 1 D). 
Phenotype of Cyclin Dl-‘- Mice 
Approximately one fourth of the offspring born in cyclin 
Dl +I- x cyclin Dl +I- crosses were found to be of the cyclin 
Dl-‘- genotype, indicating no significant embryonic lethal- 
ity. At birth, these homozygotes appeared to be indistin- 
guishable from wild-type and heterozygous littermates, al- 
though their weight was slightly lower. By 2 weeks of age, 
it became evident that the cyclin Dl-‘- mice grew more 
slowly; their growth retardation was most pronounced at 
3 weeks of age (Figure 2A). A majority of the mutant mice 
died early in life, often within the first month. These were 
usually the smallest animals, which had failed to thrive, 
suggesting that starvation contributed to their death. 
Some of the mutant animals began to gain weight after a 
delay of some weeks (Figure 2A) and survived for as long 
as 5 months. However, they continued to show lower-than- 
average weight and increased mortality. 
A neurological abnormality was indicated by the obser- 
vation that the mutant mice retracted their limbs toward 
the trunk when they were lifted by their tails, in contrast 
with wild-type and heterozygous littermates, which invari- 
ably responded by extending their legs (Figure 28). This 
abnormal leg-clasping reflex was first evident at approxi- 
mately 2 weeks of age and was most pronounced by 3 
weeks. It persisted in older animals but then involved 
clasping of only the hind limbs. The most affected of the 
young mutants remained in a clasped, flexed position for 
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Figure 2. Phenotype of Cyclin Dl+ Mice 
(A) Representativegrowth curveof wild-type, heterozygous, and cyclin 
Dl-‘- littermates, as indicated in the insert. One cyclin Dl-‘- mutant 
died at day 22; two others (with lowest weight) were moribund and 
were sacrificed on the last day of the observation period. An additional 
littermate of unknown genotype died at day 8 (data not shown). 
(B) Growth retardation and abnormal leg-clasping reflex in cyclin 
DV- mice. When lifted by their tails, mutant mice draw their limbs 
toward the trunk while the wild-type mice respond by extending their 
legs. On the left is a wild-type mouse; on the right, a cyclin Dl-‘+ mouse. 
Both mice were 4-week-old littermates. 
a few seconds after they had been returned to the cage. 
They also displayed difficulty in regaining a normal body 
position when placed on their backs. Older mutant animals 
also exhibited a hunched posture. The above phenotypes 
were evident in more than 100 cyclin Dl-‘- mice studied, 
although the severity of the symptoms varied from animal 
to animal. Cyclin Dl heterozygotes were indistinguishable 
from their wild-type littermates at all stages of life. 
Effects on Retinal Development 
Histopathological examination of cyclin Dl-‘- mice re- 
vealed essentially normal morphogenesis in all tissues an- 
alyzed (data not shown). One clear exception was pro- 
vided, however, by analysis of the retinas of these mice, 
which showed a dramatic reduction in cell numbers in all 
cell layers of the neural retina (Figures 3A and 38). In 
addition, the thickness of the inner plexiform layer, which 
is composed of cell projections connecting ganglion cells 
and the inner nuclear layer, was also reduced. Nonethe- 
less, as revealed by electron microscopy, the general ar- 
chitecture of the retina and retinal cell ultrastructure ap- 
peared well maintained (data not shown). One exception 
to this was provided by the photoreceptor outer segments, 
which appeared shortened and disorganized but con- 
tained well-formed discs (data not shown). No reduction in 
cell numbers was found in the retinal pigmented epithelial 
layer. These epithelial cells were seen to have normal mor- 
phology as revealed by electron microscopy (data not 
shown). 
The drastic reduction in retinal cell number could be 
explained by two mechanisms. It was possible that prolifer- 
ation of cyclin Dl-‘- retinal precursor cells was impaired 
during embryonic development. Alternatively, the mutant 
mice might have initially developed normal retinas that 
later experienced a massive loss of cells due to a degener- 
ative process. To distinguish between these two possibili- 
ties, we performed histologic analysis of retinas from wild- 
type and mutant embryos collected at 12.5, 14.5, 16.5, 
and 18.5 days postcoitum (dpc) and 1, 5, and 16 days 
postpartum (dpp) and at 5 months. The decreased number 
of cells in the retinas of mutant mice was observed as 
early as 16.5 dpc. The difference became even more ap- 
parent at 18.5 dpc and was pronounced at 1 and 5 dpp 
(data not shown). At 16 dpp, a time when retinal develop- 
ment is near completion, the mutant mice already dis- 
played a full-blown retinal phenotype (Figures 3A and 3B) 
that did not differ from that seen in older mutant animals up 
to 5 months of age (data not shown). These observations 
indicated that the observed reduction of retinal cell number 
was due to the severely reduced ability of mutant retinal 
cell precursors to proliferate during embryonic development. 
Electroretinographic (ERG) studies indicated that the 
hypoplastic retina was able to respond properly to light. 
Thus, electrophysiologic potentials generated in the retina 
were measured following exposure of mice to ashort pulse 
of light. Two waves of electrical signaling can be observed 
in this procedure: the a wave arises mainly from the photo- 
receptors, while the b wave is generated largely by bipolar 
cells (Stockton and Slaughter, 1989; Steinberg et al., 
1991). 
Testing of cyclin Dl-‘- mice showed an approximately 
lo-fold reduction of their ERG amplitudes (Figures 3C and 
30). Specifically, the amplitudes of the a and b waves of 
cyclin Dl mutant mice were found to be 23 f 8 flV and 
92 2 20 ftV (mean f SD), respectively, while the corre- 
sponding values for wild-type mice were 264 + 35 ~.LV (a 
wave) and 698 f 171 f~V(b wave). The observed reduction 
in ERG amplitudes could be accounted for by the reduction 
in cell number and shortened outer segments. Signifi- 
cantly, the mutant mice showed generally normal implicit 
(latency) times for both a and b waves. 
Taken together, the ERG results indicated that the cells 
in the retinas of cyclin Dl-‘- mice are fully functional, in 
consonance with the generally well-maintained architec- 
ture of their retinas. By analogy to human retinopathies 
in which similar reduction of ERG potentials does not dras- 
tically impair vision (Berson, 1993) we assume that the 
residual retinal tissue of mutant mice afforded them some 
visual capacity. The ERG and retinal structures of cyclin 
Dl heterozygotes were indistinguishable from that of wild- 









Figure 3. Retinal Abnormality in Cyclin 01-1
Mice
Histologic sections of retinas derived from a
16-day-old wild-type mouse (A) and a 16-day-
old cyclin 01-1- mouse (B). The paraffin sec-
tions were stained with hematoxylin and eosin.
Abbreviations: G, ganglion cell layer; INL, inner
nuclear layer; ONL, outer nuclear layer; PE,
retinal pigmented epithelium. Magnification,
approximately 116 x . The graphs below depict
representative ERG potentials recorded from
a 2- to 3-month-old wild-type (C) and cyclin
01 (0) mouse in response to a 0.1 Hz flash






Expression of Cyclin D1 during Mouse
Embryonic Development
In an attempt to understand these discrete, highly focused
developmental aberrations seen in cyclin 01-1- mice, we
examined the pattern of cyclin 01 mRNA expression dur-
ing embryonal development of normal mice through use
of in situ hybridization. These analyses provided a striking
and unexpected explanation for the phenotypes described
above. When the entire mouse embryo was examined,
cyclin 01 mRNA expression was found to be most intense
in the developing retina and very high in the brain (Fig-
ure 4).
The retinal expression of cyclin 01 was first observed
at 11 dpc but was most pronounced at 14.5 dpc (Figures
4A and 48). At this stage of development, the level of
expression in the retina was dramatically higher than in
all other tissues of the developing embryo except for the
brain. Within the retina, equal intensity of staining was
observed throughout the entire neural layer, while the pig-
mented epithelial layer showed no staining (Figure 48).
A composite photomicrograph of a sagittal section
through a 14.5 dpc mouse embryo demonstrates that an
exposure time that sufficed to show an intense hybridiza-
tion signal in the retina failed to reveal significant cyclin
01 expression in all other tissues (Figure 4A). We note
that an intense staining of brain ventricles (Figure 4C),
although lower than that seen in the retina, could not be
observed in Figure 4A owing to the particular sectioning
plane analyzed. Longer exposure times revealed still lower
but significant levels of cyclin 01 mRNA in several other
organs such as the sympathetic trunk, the lungs (Figure
40), and the tongue (Figure 4E).
The profound effects of cyclin 01 inactivation on retinal
development are most likely related to the intense expres-
sion of cyclin 01 in this tissue in wild-type mice. While no
specific lesions were identified in the nervous system of
mutant mice, the observed neurological phenotype and
high levels of cyclin 01 in the developing brain may also
be causally linked.
Proliferation of the Mammary Epithelium
during Pregnancy
Mutant cyclin 01-/- females that survived until adulthood
passed through sexual maturation. The breast tissue of
these mice was able to achieve a fully developed state
as judged by both histologic and whole-mount analysis
(Figures 5A and 58). The latter method makes it possible
to visualize mammary epithelial duct development. As is
evident from Figure 58, the epithelial ducts of adult mutant
mice were well developed and were able to form side
branches.
A dramatic anomaly in mammary function first became
manifest after cyclin 01-/- females delivered pups. These
females were unable to nurse because of a defect in preg-
nancy-associated mammary tissue proliferation.
The mammary epithelium of female mice normally un-
dergoes a massive expansion during pregnancy (compare
Figures 5A and 5C). Specifically, the mammary epithelial
ducts form side branches and develop numerous alveolar
structures that cluster together to form lobules that fill the
entire mammary fat pad (Figure 5E). Once secretion of
milk begins, the alveoli become distended (Figure 5G).
The mammary glands of the pregnant mutant mice pro-
vided a striking contrast with the normal pregnancy-
induced response. These mutant cyclin 01-/- glands
displayed a dramatic impairment in the expansion of mam-
mary epithelium. In particular, the development of alveolar
lobules that normally occurs during pregnancy was virtu-
ally absent in the mutant mice (Figures 50, 5F, and 5H).
The number of side branches clearly increased during the
pregnancy of the mutant mice, and small clusters of alveoli
were formed (compare Figures 58 and 50), but the overall
Figure 4. Expression of Cyclin Dl mRNA dur- 
ing Mouse Embryogenesis Detected by In Situ 
Hybridization 
(A) Composite photomicrographs of a saggital 
section of a 14.5 dpc mouse embryo. All photo- 
micrographs were taken at approximately equal 
exposure times. 
(6) Higher magnification of the retina seen in 
(A). Abbreviations: nl, neural layer of the retina; 
pl, retinal pigmented epithelium layer. 
(C) Coronal section through the brain (dien- 
cephalon) of a 13.5 dpc mouse embryo. 
(D) Transverse saction through the spinal cord 
and intercostal region of a 14.5 dpc mouse em- 
bryo. Abbreviations: b, bronchus; h, heart; I, 
lung; s, sympathetic ganglion; SC, spinal cord. 
(E) Coronal section through the oral and nasal 
cavities of a 12 dpc mouse embryo. Abbrevia- 
tions: hf, hair follicle; n, nasal septum; t, tongue; 
v, vomeronasal organ (Jacobson’s organ). 
Scale bar in (A), 500 pm; in (B), 100 urn; in 
(C)-(E) as represented in (E), 100 pm. Speci- 
mens were photographed by double exposure 
using dark-field illumination with a red filter and 
Hoechst epifluorescence optics. The blue color 
represents the Hoechst staining of cell nuclei, 
and the red represents the cyclin Dl hybridiza- 
tion signal. 
rate of expansion was inconsequential when compared 
with the pregnancy-associated epithelial proliferation 
seen in the mammary glands of wild-type mice (Figures 
5E and 5F). 
Ovarian Steroid Hormones and Estrogen Receptors 
The ovarian steriod hormones estrogen and progesterone 
are largely responsible for inducing the lobuloalveolar de- 
velopment of the breast during pregnancy (Bresciani, 
1966). Thus, it was possible that the failure of mammary 
proliferation in the cyclin Dl-‘- mutant mice was due to 
inadequate levels of these hormones. This was rendered 
less likely by the observed capacity of mutant mice to be- 
come pregnant and to bear offspring to full term and by 
the normal gross and microscopic structure of their uteri 
(data not shown). 
We reinforced this conclusion by measuring the levels 
of estrogen and progesterone in the peripheral blood of 
pregnant (16.5 dpc) mice and at 1 day after delivery in 
cyclin Dl-‘- and wild-type females. We chose 16.5 dpc 
because blood progesterone levels are known to peak at 
this time (Barkley et al., 1979). We found that the hormone 
levels in the two types of mice were comparable (Table 
1) and fell within the normal range (Barkley et al., 1979). 
Much of the hormone responsiveness is mediated by the 
estrogen receptor (ER) expressed by cells of the mammary 
gland. The expression of this receptor is required for both 
the estrogen-induced proliferation of the mammary epithe- 
lium and for responsiveness to progesterone (Haslam, 
1966a, 1969). For this reason, we compared the proportion 
of ER-positive cells in the mammary glands of nulliparous 
and pregnant (16.5 dpc) mice. In the immunoperoxidase 
method that we used to detect the ER, the intensity of 
staining quantitatively reflects the content of ER in the 
nucleus (Bacus et al., 1966) thereby allowing a rough 
estimate of the amount of ER present in cell nuclei. When 
Cdl 
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Table 1. The Levels of Steroid Hormones 
Steroid Hormone Wild Type 
Progesterone, 16.5 dpc 97.6 f 14.2 
Cyclin Dl-’ 
76.6 f 13.1 
Progesterone, 1 day after 
delivery 
Estradiol, 16.5 dpc 
Estradiol, 1 day after 
delivery 
5.0 f 1.4 4.1 f 1.0 
30.4 f 7.7 35.6 -c 4.3 
29.2 + 7.1 34.2 f 12.5 
The concentrations of progesterone and estradiol were determined in 
peripheral blood of 16.5 dpc pregnant mice (16 dpc) or 1 day after 
delivery as described in Experimental Procedures. The concentrations 
are presented as means f SD and are expressed in nanograms per 
milliliter for progesterone and picograms per milliliter for estradiol. The 
number of animals analyzed: n = 6 for wild type, 16.5 dpc; n = 4 for 
cyclin Di+, 16.5 dpc; n = 4 for wild type, 1 day after delivery; n = 
2 for cyclin Dim’+, 1 day after delivery. 
normal and mutant breast tissue was compared in this 
way, no apparent differences were observed in either the 
fraction of ER-positive ceils or in the intensity of nuclear 
staining (data not shown). 
wild-type 
We concluded that the mammaryepithelial cell prolifera- 
tion defect seen in the mutant mice during pregnancy 
could not be ascribed either to the deficiency of circulating 
ovarian steroid hormones or to the absence of ER, but 
reflected instead a defect in the hormone responsiveness 
of the target organ. 
Discussion 
The functions of the three mammalian D-type cyclins re- 
main incompletely understood. Of these three, cyclin Dl 
is the best studied. In vitro inactivation of cyclin Di by 
injection of antibodies or antisense plasmids into cultured 
fibroblasts has been found to block proliferation of these 
cells. In addition, expression of cyclin Dl has been docu- 
mented in almost all nontransformed cell lines examined 
(reviewed by Sherr, 1994). For these reasons, we antici- 
pated that a homozygous inactivation of the cyclin Dl gene 
in the mouse germline would severely compromise cell 
proliferation in the developing embryo, leading in turn to 
early embryonic lethality. 
cyclin Dl -/- Figure 5. Impaired Mammary Epithelial Expan- 
sion during Pregnancy in Cyclin Dl-I’ Mice 
The whole-mount (A-F) and histologic (G and 
H) appearance of the mammary glands derived 
from 16 to 22-weekold wild-type (A, C, E, and 
G) and cyclin Di+- (B. D, F, and H) mice. The 
whole mounts of inguinal mammary glands 
were prepared as described in Experimental 
Procedures, and the epithelial component was 
stained with carmine red. The paraffin histo- 
logic sections (G and H) were stained with he- 
matoxylin and eosin. The bar denotes 1 mm 
(A-F) or 0.2 mm (G and H). 
(A) Nulliparous wild-type mouse. 
(B) Nulliparous mutant mouse. 
(C and E) Wild-type mouse, 1.5 day after de- 
livery. 
(D and F) Mutant mouse, 1 day after delivery. 
(G) Wild-type mouse, 1 day after delivery. 
(H) Mutant mouse, 1 day after delivery. 
g&in Dl-Deficient Mice 
The observed limited effects of the cyclin Dl -‘- genotype 
were therefore unexpected. Cyclin Dl is apparently clis- 
pensable for the proliferation of the majority of tissues in 
which, we speculate, other D-type cyclins provide substi- 
tutes for its functions. We discuss three discernible conse- 
quences of cyclin Dl loss below. 
The Neurological Phenotype 
The behavioral phenotype observed in cyclin Dl-‘- mice, 
in particular the abnormal limb reflex (Figure 28) provides 
clear indication of an abnormality in the functioning of the 
nervous system. Clasping of the limbs has been reported 
in several spontaneously arising neurologic mutants and 
in mutants generated by targeted disruption of genes criti- 
cal for the development or functioning of neurons (Ur- 
banek et al., 1994, and references therein). While no obvi- 
ous histopathological abnormalities were found in the 
nervous system of cyclin Dl+ mice, minor neuroanatomi- 
cal defects might suffice to cause these neurological 
symptoms (for example, Klein et al., 1994); such lesions 
would have escaped our attention. 
Our in situ hybridization analysis did demonstrate very 
high expression of cyclin Dl mRNA in the developing brain 
(Figure 4C) and significant levels in the developing sympa- 
thetic trunk (Figure 4D), but only very low levels in the 
adult brain (data not shown). Others have reported that 
expression of cyclin Dl increases during the maturation 
of rat brain (Tamaru et al., 1993). The precise impact of 
cyclin Dl deficiency on the functional development of the 
nervous system will remain obscure until specific neu- 
roanatomical lesions can be identified in cyclin Dl-‘- 
animals. 
The Retinal Phenotype 
In striking contrast with the great majority of mouse tissues 
in which loss of cyclin Dl is inconsequential for develop- 
ment, we find that the retinal precursor cells are critically 
dependent on cyclin Dl for their proliferation. Independent 
of this observation was the finding of extremely high levels 
of cyclin Dl expression in this tissue. As is evident from 
Figure 4A, the level of cyclin Dl mRNA in the developing 
retina is dramatically higher than that seen in all other 
tissues during a period when many embryonal tissues are 
known to be in a highly proliferative state (Kaufman, 1992). 
These observations provide us with a rationale for the de- 
scribed retinal phenotype. Thus, we speculate that the 
proliferation of cells in the developing neural retina is 
driven by and indeed requires unusually high levels of 
cyclin Dl. 
We are also struck by the fact that a rare malignancy 
of this tissue, retinoblastoma, led to the discovery of im- 
portant mechanisms regulating progress of the cell through 
the Gl phase of the cell cycle. Cyclin Dl, working with its 
partner CDKs, is known to be responsible for triggering 
pRB phosphorylation and functional inactivation (reviewed 
by Weinberg, 1995). Furthermore, cyclin Dl is able to bind 
pRB directly (reviewed by Sherr, 1994). Given this connec- 
tion, it seems more than a coincidence that two indepen- 
dent lines of experimentation, one studying the human 
Rb gene and the other the mouse cyclin Dl gene, have 
converged on this small, highly specialized tissue. 
Recognizing the clear differences between human and 
mouse retinas, notably the lack of retinoblastomas in 
IX-‘- mice (Clarke et al., 1992; Jacks et al., 1992; Lee et 
al., 1992) we suggest that this apparent coincidence may 
reflect some common underlying molecular process re- 
sponsible for regulating retinal cell proliferation and differ- 
entiation. For example, retinal cells may require especially 
high levels of pRB to block Gl progression prior to end- 
stage differentiation. Retinal cells may also express espe- 
cially high levels of cyclin Dl to neutralize pRB when prolif- 
eration is required during normal development. Such high 
dependence on pRB may in turn create a special predilec- 
tion for malignant retinal cell transformation should pRB 
function be compromised by Rb gene mutation. 
Breast Epithelial Phenotype 
Most striking was the severe impairment of mammary epi- 
thelial cell proliferation in mutant mice during pregnancy. 
As is the case in humans, the intense proliferation of the 
mouse mammary epithelium occurs during two well- 
defined periods of life, namely, ductal elongation at pu- 
berty and ductal side branching and lobuloalveolar forma- 
tion during pregnancy. The ductal elongation seen at 
puberty is directly stimulated by estrogen but is refractory 
to progesterone treatment (Haslam, 1988b). 
Once mice reach sexual maturity and their breast tissue 
becomes fully developed, the mammary epithelial cells 
acquire progesterone receptors and no longer proliferate 
in response to estrogen alone. Indeed, they now require 
both estrogen and progesterone for their proliferation, 
which results in ductal side branching and lobuloalveolar 
development during pregnancy (Wang et al., 1990). We 
also note that expression of the progesterone receptor is 
induced by the action of estrogen in adult but not devel- 
oping mammary epithelium (Haslam, 1988a). 
It isclearthatthemammaryglandsof cyclin Dl-l-mutant 
females attain an essentially fully developed state during 
sexual maturation, as evidenced by both whole-mount 
analysis (Figure 58) and histology (data not shown) The 
possibility of some subtle retardation of this development 
could not be ruled out in our study owing to the limited 
number of animals analyzed and their mixed genetic back- 
ground. A clear and dramatic impairment of mammary 
gland proliferation is first observed during pregnancy. 
While the mammary epithelium of wild-type animals devel- 
ops numerous side branches and forms large clusters of 
alveoli (Figures 5C, 5E, and 5G), this pregnancy-associated 
response in the mutant mice is dramatically reduced (Fig- 
ures 5D, 5F, and 5H). 
Numerous hormones have been found to act in concert 
to induce full development and lactation of the mammary 
gland during pregnancy. Included here are the ovarian 
steroids estrogen and progesterone, the pituitary hor- 
mones prolactin and growth hormone, as well as adrenal 
steroids (Nandi, 1958). However, the critical role in stimu- 
lating mammary epithelial proliferation during this period 
has been ascribed to the ovarian steroids (Haslam, 1988b; 
Wang et al., 1990). 
As reported here, the observed phenotype cannot be 
ascribed to the absence of ovarian hormones in the preg- 
nant mutant females or to the lackof ERs in their mammary 
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epithelial cells. We anticipate that the progesterone recep- 
tors will also be present in normal levels in the mutant 
breast but were unable to demonstrate this directly owing 
to the lack of appropriate reagents. We speculate that the 
lack of a proliferative response of the mutant cells is due 
to a downstream defect in signaling. 
A critical role played by cyclin Dl in the regulation of 
mammary epithelial proliferation has long been sus- 
pected. Cyclin Dl gene amplification and protein overex- 
pression have been demonstrated in a large fraction of 
human breast cancers (Buckley et al., 1993; Bartkova et 
al., 1994) and have been shown to correlate with poor 
prognosis and the presence of lymph node metastases 
(Schuuring et al., 1992). The above observations are paral- 
leled by the finding that transgenic mice engineered to 
overexpress cyclin Dl in their breast tissue display mam- 
mary hyperplasia and succumb to breast cancers (Wang 
et al., 1994). 
The in vivo expression pattern of D cyclins in the normal 
breast remains unclear. However, expression of all three 
D-type cyclins has been detected in breast epithelial cells 
cultured in vitro, cyclin Dl being rapidly induced following 
the exposure of these cells to various mitogens (Motokura 
et al., 1992; Buckley et al., 1993; Musgrove et al., 1993; 
C. Brisken and R. A. W., unpublished data). In addition, 
a link between cyclin Dl and ovarian steroid hormones is 
suggested by the observation that in human breast can- 
cers, the overexpression of cyclin Dl correlates with the 
expression of ERs and most likely progesterone receptors 
(Adnane et al., 1989; Buckley et al., 1993). Finally, cyclin 
Dl -overexpressing breast cancer cells appear to depend 
critically on cyclin Dl for cell cycle progression, as the 
inactivation of cyclin Dl by injected antibodies or anti- 
sense oligonucleotides severely delays their entry into the 
S phase (Bartkova et al., 1994), while ectopic induction 
of cyclin Dl in ER-positive breast cancer cell line is suffi- 
cient for cell cycle progression (Musgrove et al., 1994). For 
these reasons, some have proposed that in ERcontaining 
breast cancer cells, the proliferative action of steroids is 
mediated by cyclin Dl (Musgrove et al., 1993; Sutherland 
et al., 1993; Watts et al., 1994). The present data lend 
considerable weight to the notion that the ovarian hor- 
mones act via cyclin Dl to drive the proliferation of mam- 
mary epithelial cells. However, in the absence of direct 
biochemical data, alternative mechanistic explanations 
can be entertained. 
Our finding that the only obvious antiproliferative effects 
of cyclin Dl inactivation in adult mice are restricted to the 
mammary epithelium may encourage the development of 
therapeutic agents that specifically antagonize this cyclin. 
Such agents might prove to be highly selective in the treat- 
ment of malignancies of the breast while sparing the func- 
tion of the other proliferating tissues in the adult, 
The analysis of cyclin Dl-deficient mice has provided 
two important links between developmental biology and 
cancer. In both breast and retinal tissue, the absence of 
cyclin Dl has led to striking, highly specific developmental 
abnormalities. Evidence from other sources indicates that 
the cyclin DlpRB pathway is also perturbed during the 
tumorigenesis that occurs in these tissues; pRB function 
is lost in retinoblastomas while cyclin Dl function is ampli- 
fied in many breast carcinomas (Buckleyet al., 1993; Bart- 
kova et al., 1994). These links might suggest that tissues 
that are driven to malignant transformation by the actions 
of certain genes may also show a special dependence 
on those particular genes for their normal development. 
Accordingly, an understanding of the specific develop- 
mental pathways utilized in various tissues may allow in- 
sights into the nature of the genes that play important roles 
in the conversion of these tissues to the malignant state. 
Experimental Procedures 
Generation of Cyciln Dl-‘- Mice 
The mouse cyclin Dl gene was isolated by screening a XDASH (Stra- 
tagene) mouse genomic library derived from the 129/Sv mouse strain, 
using as a probe a 300 bp BssHii 5’ fragment of human cyciin Dl 
cDNA (provided by Dr. A. Arnold). Positive clones were subcloned 
into pGEM-42 piasmid vector (Promega). Restriction mapping, DNA 
sequencing of coding portions and of exon-intron junctions, as well 
as hybridization with exon-specific oiigonucleotide probes yielded the 
restriction map shown in Figure 1A. 
A gene targeting vector was prepared as follows. A 3700 bp Eagi 
fragment of the mouse cyciin Dl gene (Sto the first coding exon) was 
filled in and subcloned into a blunted Xhol site of the pPNT vector 
(Jacks et al., 1992). yielding a 3700-pPNT plasmid. The 3400 bp Xbai- 
EcoRi genomic fragment (the EcoRi site deriving from the 1 vector 
poiyiinker sequence) was assembled in pGEM-42 piasmid. This frag- 
ment was released by digesting poiyiinker sequences with Asp71 8 and 
EcoRi and subcloned into Asp718- and EcoRidigested 3700-pPNT, 
yielding a cyclin Dl gene targeting vector. 
Notl-linearized targeting vector was electroporated into D3 ES cells 
(Gossier et al., 1986). G418 and gancyciovir double-resistant ES 
clones were selected, expanded, and frozen essentially as described 
previously (Jacks et al., 1992). The homologous recombination event 
is predicted to replace a 5200 bp Eagi-Xbai fragment of the cyciin 
Dl gene with a neo gene. 
DNAwas isolated from 141 double-resistant ES cell clones, digested 
with Xbai, blotted onto Hybond-N membranes, and probed with a 500 
bp Taql fragment of the cyciin Dl gene (probe A in Figure 1). The 
probe hybridizes to a 9.6 kb Xbai fragment derived from the wild-type 
allele, while the targeted locus is predicted to yield a 6.2 kb fragment 
(Figures 1A and 18). Of the 52 ES ceil clones that were scored as 
being heteroxygous at the cyciin Dl locus, six were expanded and 
their genetic status further validated. Thus, the presence of additional 
integration sites was ruled out by probing Xbai digests of their genomic 
DNA with a neo gene probe; additionally Sfii-Asp718 digests were 
probed with a 1400 bp EcoRl fragment of cyciin Dl gene (3’ EcoRi 
site derived from the polyiinker; probe B in Figure 1). 
Cyciin Dl heteroxygous ES ceils were injected into blastocyst-stage 
C57BU6 mouse embryos (approximately 15 ceils per blastocyst) and 
implanted into pseudopregnant ICR females as described previously 
(Jacks et al., 1992). The resulting chimeras were bred to C57BU6 
mice. The germiine transmission of injected ES ceils was scored by 
the inheritance of agouti color and by the genotyping of these animals. 
The resulting cyciin Dl heterozygotes were bred to produce homoxy- 
gous mice. For the genotyping, genomic DNA was isolated from animal 
tails, digested with Xbai, and analyzed by Southern blotting using 
probe A or by PCR (Figure 1C). PCR was performed by denaturing 
the DNA at 94% for 1 min, followed by 30 cycles of amplification: 
94% for 1 min, 66% for 1 min, 72W for 1 min, and a final extension 
step at 72% for 5 min. The following cyciin Di-specific primers were 
used (Figures 1 A and 1C): C (5’-TAG CAG AGA GCT ACA GAC TTC 
G-31, H (Y-CTC CGT CTT GAG CAT GGC TC-3’). and a neo gene- 
specific primer, N (5”CTA GTG AGA CGT GCT ACT TC-3’). 
Embryonic fibrobiasts were isolated from 13.5 dpc wild-type or cyciin 
Dl embryos essentially as described previously (Robertson, 1987) 
iysed in Laemmli sample buffer, separated using SDS-PAGE, and 
transferred to immobilon P membrane (Miiiipore). Rabbit poiycional 
anti-cyclin Dl antibody (serum #19; a gift of Dr. E. Harlow’s lab) was 
used as a primary antibody at 1 :lOOO dilution; peroxidase-conjugated 
C&in Dl-Deficient Mice 
goat anti-rabbit IgG (Jackson ImmunoResearch) was used as a sec- 
ondary antibody at I:5000 dilution followed by enhanced chemilumi- 
nescence (ECL) detection (Amersham). 
Histology and Electron Microscopy 
For histology, mice were perfused with Bouin’s fixative (Sigma). Tis- 
sues were dissected, fixed further in Bouin’s fixative, processed, and 
embedded in paraffin using standard procedures. Sections (6 urn) 
were cut and stained with hematoxylin and eosin. Alternatively, tissues 
were fixed in 4% formaldehyde in 0.1 M phosphate buffer, infiltrated 
with 30% sucrose in the same buffer, mounted in OCT medium (Miles), 
and snap-frozen in isopentane. Cryostat sections (10 pm thick) were 
cut and stained with hematoxylin and eosin. 
For electron microscopy, enucleated eyes were fixed overnight in 
1% formaldehyde and 2.5% glutaraldehyde in phosphate-buffered sa- 
line (PBS). The eye cups were then postfixed in osmium tetroxide and 
embedded in Epon. Ultrathin sections (SO-80 nm) were cut, stained 
with uranyl acetate and lead citrate, and viewed under a JEOL 1OOC 
transmission electron microscope. 
ERG Testing 
Mice were adapted to the dark for 12 hr before testing. Testing was 
conducted essentially as described previously (Olsson et al., 1992) 
except that electrodes were placed in direct contact with the cornea. 
ERGS were elicited from one eye of each animal with 0.1 Hz, 10 us 
flashes of bright white light. Signals were differentially amplified, digi- 
tized, and filtered. We tested five wild-type and five cyclin Dl-‘- mice. 
For each animal analyzed, four separate responses were generated, 
and a composite tracing was averaged by computer. Representative 
tracings for each genotype are presented in Figures 3C and 30. With 
this setup, the a wave amplitudes in wild-type adult pigmented mice 
fall in the range between 100-300 pV, while b wave amplitudes fall 
in the range of 400-1200 uV. The implicit (flash onset to peak) times 
are in the range of 15-30 ms for the a waves and 45-75 ms for the 
b waves (T. L. and B. Pawlyk, unpublished data). 
In Situ Hybridlzatlon 
In situ hybridizations were performed on mouse embryos from 9 to 
14.5 dpc and on adult tissues as previously described (Wilkinson, 
1993; Parker et al., 1995). Standard protocols for collecting, embed- 
ding, and sectioning the tissues were employed. pBluescript mouse 
cyclin Dl cDNA (Matsushime et al., 1991 b) was linearized with Hindlll, 
and antisense transcripts were generated using T3 polymerase. Speci- 
mens were hybridized with [36S]UTP-labeled riboprobes. 
Mammary Gland Whole Mounts 
lnguinal mammary glands were dissected, spread onto a glass slide, 
fixed in a 1:3 mixture of glacial acetic acid:ethanol, hydrated, stained 
overnight in 0.2% carmine (Sigma) and 0.5% AIK(SO&, dehydrated 
in graded solutions of ethanol, and cleared in toluene and methyl 
salicylate essentially as described previously (Wang et al., 1990). 
Measurement of Serum Sterold Hormone Levels 
Peripheral blood was collected from the orbital venous sinus of preg- 
nant mice (16.5 dpc) or 1 day after delivery. Serum was collected by 
centrifugation and kept at -80°C. Progesterone and estradiol levels 
were measured by immunoassay using rabbit polyclonal antibodies 
generated by the Reproductive Endocrine Unit Laboratory at Massa- 
chusetts General Hospital (Boston, MA) as described previously (Hall 
et al., 1992). 
ER lmmunocytochemlstry 
lnguinal mammary glandswere dissected from nulliparous or pregnant 
(16.5 dpc) mice, mounted in OCT compound (Miles), and snap-frozen 
in isopentane. Cryostat sections (6 pm) were fixed for 5 min at room 
temperature in 10% formalin in PBS, followed by methanol for 3-5 
min at -lO°C, acetone for 1-3 min at -lO°C, and two rinses in PBS 
for 5 min each. The immunoperoxidase staining was performed as 
described previously (Haslam and Nummy, 1992) with the exception 
that the ImmunoPure metal-enhanced DAB substrate kit (Pierce) was 
used for chromagen development. Nuclei were counterstained with 
1% methyl green for 1 min. Anti-ER monoclonal antibody H222 was 
a gift of Abbott Labs. 
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